Ad-hoc release
July 21, 2026
Preliminary numbers for Q2 2026 exceed market expectation - increase of guidance for fiscal year 2026
Based on preliminary figures, GEA achieves an order intake of €1.49 billion in the second quarter of 2026 (VARA consensus: €1.41 billion). Revenue stands at €1.44 billion (VARA consensus: €1.38 billion), with organic revenue growth* amounting to 11.0 percent (VARA consensus: 6.3 percent). EBITDA before restructuring expenses* is €250 million (VARA consensus: €233 million), with a corresponding EBITDA margin* of 17.4 percent (VARA consensus: 16.9 percent).
Therefore, GEA raises its guidance for fiscal year 2026 as follows:
VARA-consensus as of July 15th, 2026
*Notes on key performance indicators used can be found in the annual report 2025 of GEA Group AG on page 26.
GEA is one of the world’s largest suppliers of systems and components to the food, beverage and pharmaceutical industries.
The international technology group, founded in 1881, focuses on machinery and plants, as well as advanced process technology, components and comprehensive services. For instance, every second pharma separator for essential healthcare products such as vaccines or novel biopharmaceuticals is produced by GEA. In food, every fourth package of pasta or every third chicken nugget are processed with GEA technology.
With more than 18,000 employees, the group generated sales of about EUR 5.5 billion in more than 150 countries in the 2025 fiscal year. GEA plants, processes, components and services enhance the efficiency and sustainability of customers’ production. They contribute significantly to the reduction of CO2 emissions, plastic usage and food waste. In doing so, GEA makes a key contribution toward a sustainable future, in line with the company’s purpose: ”Engineering for a better world.”
GEA is listed on the German DAX, the European STOXX® Europe 600 Index and is also a constituent of the leading sustainability indices DAX 50 ESG, MSCI Global Sustainability and Dow Jones Best-in-Class World.